GR1000951B - Μειωση της διαδοσης λοιμωξεως δια μεσου του εξοπλισμου χειρισμου αιματος. - Google Patents

Μειωση της διαδοσης λοιμωξεως δια μεσου του εξοπλισμου χειρισμου αιματος.

Info

Publication number
GR1000951B
GR1000951B GR900100435A GR900100435A GR1000951B GR 1000951 B GR1000951 B GR 1000951B GR 900100435 A GR900100435 A GR 900100435A GR 900100435 A GR900100435 A GR 900100435A GR 1000951 B GR1000951 B GR 1000951B
Authority
GR
Greece
Prior art keywords
infection
monoglycerides
fatty acids
relates
rediucing
Prior art date
Application number
GR900100435A
Other languages
English (en)
Other versions
GR900100435A (en
Inventor
C William Heird
E Charles Isaacs
S Kwang Kim
Halldor Thormar
Original Assignee
Res Found Mental Hygiene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Found Mental Hygiene filed Critical Res Found Mental Hygiene
Publication of GR900100435A publication Critical patent/GR900100435A/el
Publication of GR1000951B publication Critical patent/GR1000951B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/06—Unsaturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Αυτή η εφεύρεση αναφέρεται σε δράση κατά των ιών και αντιβακτηριακή δράση των λιπαρών οξέων και μονογλυκεριδίων. Ειδικότερα αυτή η εφεύρεση αναφέρεται στην απενεργοποίηση ιών που φέρουν περίβλημα και στην εξόντωση κυττάρων υπό λιπαρών οξέων και μονογλυκεριδίων. Η εφεύρεση αναφέρεται επίσης σε ιοκτόνες ή/και αντιβακτηριακές φαρμακευτικές συνθέσεις που αποτελούνται ουσιαστικά από αδρανή φαρμακευτικό φορέα και αποτελεσματική ποσότητα μιας ή περισσοτέρων ενώσεων εκλεγομένων από την ομάδα που αποτελείται από λιπαρά οξέα και μονογλυκερίδιά τους και στη χρήση των εν λόγω ενώσεων στην μείωση του κινδύνου λοίμωξης σε διαδικασίες χειρισμού προϊόντων αίματος. ω
GR900100435A 1989-06-12 1990-06-11 Μειωση της διαδοσης λοιμωξεως δια μεσου του εξοπλισμου χειρισμου αιματος. GR1000951B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36529189A 1989-06-12 1989-06-12

Publications (2)

Publication Number Publication Date
GR900100435A GR900100435A (en) 1991-11-15
GR1000951B true GR1000951B (el) 1993-03-16

Family

ID=23438269

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100435A GR1000951B (el) 1989-06-12 1990-06-11 Μειωση της διαδοσης λοιμωξεως δια μεσου του εξοπλισμου χειρισμου αιματος.

Country Status (10)

Country Link
EP (1) EP0429645A4 (el)
JP (1) JPH04501570A (el)
KR (1) KR920700635A (el)
AU (1) AU5945590A (el)
BR (1) BR9006800A (el)
CA (1) CA2032484A1 (el)
FI (1) FI902821A0 (el)
GR (1) GR1000951B (el)
NZ (1) NZ233990A (el)
WO (1) WO1990015601A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
FI912955A (fi) * 1990-06-25 1991-12-26 Res Found Mental Hygiene Antimikroba fettsyrasammansaettningar.
EP0702556B1 (en) * 1993-06-10 2002-10-23 Wake Forest University (phospho)lipids for combatting hepatitis b virus infection
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5962437A (en) 1994-08-29 1999-10-05 Wake Forest University Lipid analogs for treating viral infections
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
KR100871648B1 (ko) 2001-08-31 2008-12-03 톰슨 라이센싱 조건부 액세스 시스템을 구현하는 방법, 컨텐트를 전송하는 방법 및 그 장치 및 컨텐트를 수신하고 처리하는 방법 및 그 장치
US20050215634A1 (en) * 2003-11-11 2005-09-29 Schlievert Patrick M Regulation of cell membrane-mediated effects
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
EP1833298B1 (en) * 2004-12-17 2013-05-08 Halldor Thormar Stable concentrated anti-bacterial emulsions of monocaprin in water
WO2006130529A1 (en) * 2005-05-31 2006-12-07 Pierce Biotechnology, Inc. Extraction of cellular components with fatty acid derivatives
JP2010163397A (ja) * 2009-01-16 2010-07-29 Japan Ecologia Co Ltd 抗菌性組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0021504B1 (en) * 1979-06-25 1984-10-03 THE PROCTER & GAMBLE COMPANY Article for use as catheter or the like
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
WO1988009655A1 (en) * 1987-06-05 1988-12-15 Al Sioufi Habib Method and device for disinfecting biological fluids and container for same
US4853978A (en) * 1987-07-24 1989-08-08 Surgikos, Inc. Antimicrobial medical glove
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides

Also Published As

Publication number Publication date
KR920700635A (ko) 1992-08-10
GR900100435A (en) 1991-11-15
WO1990015601A1 (en) 1990-12-27
JPH04501570A (ja) 1992-03-19
FI902821A0 (fi) 1990-06-06
EP0429645A1 (en) 1991-06-05
CA2032484A1 (en) 1990-12-13
EP0429645A4 (en) 1992-05-13
NZ233990A (en) 1992-01-29
AU5945590A (en) 1991-01-08
BR9006800A (pt) 1991-08-06

Similar Documents

Publication Publication Date Title
GR1000958B (el) Αντιμικροβιακες συνθεσεις λιπαρων οξεων.
GR1000951B (el) Μειωση της διαδοσης λοιμωξεως δια μεσου του εξοπλισμου χειρισμου αιματος.
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
NZ215939A (en) Phosphonyl methoxyadenine antiviral compositions
LU79627A1 (de) Steril verschliessbarer behaelter
FI935303A (fi) Ei-ionisten, samepistettä modifioivien aineiden käyttö nanohiukkasten kasautumisen minimoimiseen steriloinnin aikana
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE3674941D1 (de) Ozonentkeimung von blut und blutprodukten.
DK153775C (da) Ikke-absorberbar, steril, kirurgisk sutur eller ligatur
CY1110490T1 (el) Πεπτιδια που σχετιζονται με το συν-πολυμερες (copolymer) 1 για χρηση σαν παραγοντες σημανσης μοριακου βαρους και για θεραπευτικη χρηση
ES2104556T3 (es) Peptidos que tienen propiedades inmunologicas de hiv-2.
IT1205337B (it) Derivati amminometil-benzenici eteroaril-sostituiti ad attivita' regolatrice del ritmo cardiaco e composizioni farmaceutiche che li contengono
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
IT1062525B (it) 2.3.6 tricloro 4 cian 4 benzoilureido difenileteri procedimento per la loro preparazione e il loro impiego come insetticidi
IT1141039B (it) Formulazioni biodegradabili che favoriscono la crescita e procedimento di trattamento
CO4520283A1 (es) Agentes antivirales
DE3575859D1 (de) Arzneimittel fuer die behandlung von involutiven gehirnsyndromen und von geistigem verfall.
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
SE7611871L (sv) Medel okande tillvexten
MX9305523A (es) Composiciones quimoterapeuticas mejoradas frente a infecciones microbianas en peces, la reparacion y uso de las mismas.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
ES2062302T3 (es) Determinadas glioxil-ciclohexenodionas.
ATE26267T1 (de) Pyrimidin-derivate, ausgestattet mit antiviraler wirkung.
BR8700693A (pt) Expelentes de microbios fitopatogenicos e composicao expelente de microbios fitopatogenicos